A retrospective study of the usefulness of perflubutane contrast in ultrasound endoscopy

A retrospective study of the usefulness of perflubutane contrast in ultrasound endoscopy - A retrospective study of the usefulness of perflubutane contrast in ultrasound endoscopy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055846

Enrollment

Registered

2024-10-16

Start date

2024-10-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Submucosal tumors of the digestive tract, biliary system tumors, pancreatic tumors, intraperitoneal lymph node enlargement, peritoneal dissemination, etc.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Cases where consent for off-label use has been obtained. 2) Cases where perfluorobutane imaging was performed using an ultrasound endoscope.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Diagnostic benefit of perfluorobutane-enhanced endoscopic ultrasound	—

Countries

Japan

Contacts

Public ContactNOBUHIKO FUKUBA

Shimane University Internal medicine II

nfukuba@med.shimane-u.ac.jp0853-23-2111

Outcome results